{"id":38090,"date":"2024-12-03T05:56:18","date_gmt":"2024-12-03T05:56:18","guid":{"rendered":"https:\/\/www.euforea.org\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/"},"modified":"2026-08-27T07:35:40","modified_gmt":"2026-08-27T07:35:40","slug":"reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024","status":"publish","type":"events","link":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/","title":{"rendered":"R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"38090\" class=\"elementor elementor-38090 elementor-5610\" data-elementor-post-type=\"events\">\n\t\t\t\t<div class=\"elementor-element elementor-element-48271849 e-con-full e-flex wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent\" data-id=\"48271849\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5dda2998 elementor-widget elementor-widget-Banner\" data-id=\"5dda2998\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"Banner.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"region-header__image clearfix\">\n  <div class=\"region region-header\">\n    <div class=\"views-element-container contextual-region\" id=\"block-views-block-header-block-header\">     \n      <div class=\"contextual-region view view-header view-id-header view-display-id-block_header js-view-dom-id-b48dd413984a0ee80d7b5411a5f0b6aea012ca5b777f404297919f57b78319de\">        \n        <div class=\"view-content\">\n          <div data-history-node-id=\"697\" data-quickedit-entity-id=\"node\/697\" role=\"article\" class=\"contextual-region header\" about=\"\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n            <div class=\"header__bg\">\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-develop\/uploads\/Consensus-Meeting-on-Severe-Rhinitis-Page.png\" width=\"1400\" height=\"500\" alt=\"\" loading=\"lazy\" typeof=\"foaf:Image\" class=\"image-style-header\">\n            <\/div>            \n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6c23b1d5 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent\" data-id=\"6c23b1d5\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1e5a959 elementor-widget elementor-widget-euforea_general_breadcrumb\" data-id=\"1e5a959\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"euforea_general_breadcrumb.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"inner--wide\">\n  <div id=\"block-novtheme-breadcrumbs\" class=\"contextual-region\">    \n    <nav class=\"breadcrumb\" role=\"navigation\" aria-labelledby=\"system-breadcrumb\">\n        <h2 id=\"system-breadcrumb\" class=\"visually-hidden\">Breadcrumb<\/h2>\n        <ul class=\"breadcrumb__list\"><li class=\"breadcrumb__list-item\">\n                <a class=\"breadcrumb__link\" href=\"https:\/\/www.euforea.org\/fr\/\">Home<\/a>\n              <\/li><\/ul><\/nav>  <\/div>\n  <h1 class=\"node__title\">\n    <span data-quickedit-field-id=\"node\/697\/title\/en\/full\" class=\"field field--name-title field--type-string field--label-hidden quickedit-field\" data-once=\"quickedit\">R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024<\/span>\n  <\/h1>\n  <\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-35a56596 elementor-widget elementor-widget-euforea_general_content\" data-id=\"35a56596\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"euforea_general_content.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"paragraphs\">\n    <div data-quickedit-entity-id=\"paragraph\/842\" class=\"paragraph paragraph--text-columns paragraph-id--842 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n      <div class=\"inner--wide\">\n        <div class=\"text__text text text--paragraph\">\n        \t          <p>La rhinite allergique (RA) est la maladie immunologique la plus fr\u00e9quente, touchant quelque 400 millions de personnes dans le monde. Elle varie d\u2019une g\u00eane mineure \u00e0 une RA s\u00e9v\u00e8re : une maladie d\u00e9bilitante ayant un impact significatif sur la qualit\u00e9 de vie (QdV). De plus, la RA est susceptible d\u2019entra\u00eener plusieurs comorbidit\u00e9s, dont l\u2019asthme allergique.  <\/p>\n<p>Avec les nouvelles connaissances et options de traitement disponibles, il est de plus en plus n\u00e9cessaire de (re)d\u00e9finir les d\u00e9finitions cl\u00e9s afin de permettre la communication entre les diff\u00e9rentes sp\u00e9cialit\u00e9s traitant la RA. Le Forum europ\u00e9en pour la recherche et l\u2019\u00e9ducation sur l\u2019allergie et les maladies des voies respiratoires (EUFOREA) organisera une r\u00e9union d\u2019experts de diff\u00e9rentes sp\u00e9cialit\u00e9s traitant la RA afin de trouver un consensus sur plusieurs d\u00e9finitions et stades de la maladie. <\/p>\n<p>S\u2019appuyant sur les r\u00e9unions de consensus sur l\u2019asthme (Londres, avril 2023) et la RSC (Bruxelles, juin 2023), l\u2019EUFOREA se concentrera d\u00e9sormais sur la RA en tant que maladie afin de trouver un consensus sur les nouveaux stades de la maladie et les cibles th\u00e9rapeutiques.<\/p>\n<p>Cet \u00e9v\u00e9nement se tient sur invitation !<\/p>\n<h3><b>D\u00e9finir les points suivants :<\/b><\/h3>\n<ul>\n<li>Le contr\u00f4le de la RA<\/li>\n<li>La r\u00e9mission et la gu\u00e9rison de la RA<\/li>\n<li>La r\u00e9currence\/exacerbation de la RA<\/li>\n<li>La modification de la maladie dans la RA<\/li>\n<li>Conseiller sur la pr\u00e9vention de la RA<\/li>\n<li>Les lacunes dans la prise en charge de la RA<\/li>\n<li>Suggestions pour am\u00e9liorer la prise en charge de la RA<\/li>\n<li>Ambitions futures pour la prise en charge de la RA<\/li>\n<\/ul>\n        <\/div>\n      <\/div>\n    <\/div>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-afbac39 elementor-widget elementor-widget-embedpress_pdf\" data-id=\"afbac39\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"embedpress_pdf.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t    <div class=\"embedpress-document-embed ep-doc-9f28a12c0be33a04621b90f5829c624d ose-document emebedpress-unit-percent \" data-thememode=\"default\" data-customcolor=\"\" data-toolbar=\"yes\" data-toolbar-position=\"top\" data-open=\"no\" data-presentation-mode=\"yes\" data-download=\"yes\" data-copy=\"yes\" data-add-image=\"yes\" data-rotate=\"yes\" data-details=\"yes\" data-id=\"embedpress-pdf-afbac39\" data-selection-tool=\"0\" data-scrolling=\"0\" data-spreads=\"-1\" style=\" max-width:100%; display: inline-block\">\n\n        \n                <div >\n\n                    <div id=\"ep-elementor-content-afbac39\" class=\"ep-elementor-content   ep-percentage-width   ep-content-protection-disabled\">\n                        <div id=\"afbac39\" class=\"ep-embed-content-wraper\">\n                            <div><iframe title=\"R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024\" class=\"embedpress-embed-document-pdf embedpress-pdf-afbac39\" allowfullscreen=\"true\" mozallowfullscreen=\"true\" webkitallowfullscreen=\"true\" style=\"width: 1330%!important;height: 600px;; max-width:100%;\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-develop\/uploads\/AR-Consensus-Meeting-Agenda.pdf\" class=\"embedpress-embed-document-pdf embedpress-pdf-afbac39\" data-emid=\"embedpress-pdf-afbac39\" data-embed-type=\"PDF\" data-ep-views=\"off\" data-ep-downloads=\"off\"><\/iframe><\/div>                        <\/div>\n\n                    <\/div>\n\n\n                   \n                <\/div>\n            \n    <\/div>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e83860b elementor-widget elementor-widget-Team\" data-id=\"e83860b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"Team.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"paragraphs\">\n\t\t\t<div data-quickedit-entity-id=\"paragraph\/103\" class=\"paragraph paragraph-id--103 paragraph--type--team paragraph--view-mode--default team clearfix\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n\t  <div class=\"inner--wide\">\n\t  \t\t    \t<h2 class=\"paragraph__title\">Membres du corps professoral<\/h2>\n\t\t\t    <div class=\"team__container\">\n\t    \t\t\t      <a data-quickedit-entity-id=\"paragraph\/1874\" class=\"paragraph paragraph-id--1874 paragraph--type--team-member paragraph--view-mode--default team__member clearfix\" style=\"background-image:url(https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Scadding20Glenis1.jpg?h=061f5bdf&amp;itok=EcJlcMtf)\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n\t\t        \t\t\t        \t<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/gb.svg\" class=\"team__member__flag\">\n\t\t\t        \t\t        <div class=\"team__member__overlay\">\n\t\t        \t\t\t          \t<div class=\"team__member__name\"> Prof. Glenis Scadding <\/div>\n\t\t          \t\t          \t\t          <div class=\"team__member__function\"> Copr\u00e9sidente de l\u2019\u00e9v\u00e9nement <\/div>\n\t\t      \t\t\t        <\/div>\n\t\t      <\/a>\n\t  \t\t\t\t      <a data-quickedit-entity-id=\"paragraph\/1874\" class=\"paragraph paragraph-id--1874 paragraph--type--team-member paragraph--view-mode--default team__member clearfix\" style=\"background-image:url(https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Philippe20Gevaert20Photo1.jpeg?h=061f5bdf&amp;itok=EcJlcMtf)\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n\t\t        \t\t\t        \t<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/be.svg\" class=\"team__member__flag\">\n\t\t\t        \t\t        <div class=\"team__member__overlay\">\n\t\t        \t\t\t          \t<div class=\"team__member__name\"> Pr Philippe <br\/>Gevaert <\/div>\n\t\t          \t\t          \t\t          <div class=\"team__member__function\"> Copr\u00e9sidente de l\u2019\u00e9v\u00e9nement <\/div>\n\t\t      \t\t\t        <\/div>\n\t\t      <\/a>\n\t  \t\t\t\t      <a data-quickedit-entity-id=\"paragraph\/1874\" class=\"paragraph paragraph-id--1874 paragraph--type--team-member paragraph--view-mode--default team__member clearfix\" style=\"background-image:url(https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Sophie20Scheire1.png?h=061f5bdf&amp;itok=EcJlcMtf)\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n\t\t        \t\t\t        \t<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/be.svg\" class=\"team__member__flag\">\n\t\t\t        \t\t        <div class=\"team__member__overlay\">\n\t\t        \t\t\t          \t<div class=\"team__member__name\"> Dr Sophie Scheire <\/div>\n\t\t          \t\t          \t\t        <\/div>\n\t\t      <\/a>\n\t  \t\t\t\t      <a data-quickedit-entity-id=\"paragraph\/1874\" class=\"paragraph paragraph-id--1874 paragraph--type--team-member paragraph--view-mode--default team__member clearfix\" style=\"background-image:url(https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Joaquim20Mullol1.jpg?h=061f5bdf&amp;itok=EcJlcMtf)\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n\t\t        \t\t\t        \t<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/es.svg\" class=\"team__member__flag\">\n\t\t\t        \t\t        <div class=\"team__member__overlay\">\n\t\t        \t\t\t          \t<div class=\"team__member__name\"> Prof. Joaquim Mullol <\/div>\n\t\t          \t\t          \t\t        <\/div>\n\t\t      <\/a>\n\t  \t\t\t      \n\t    <\/div>\n\t  <\/div>\n\t<\/div>\n\t<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Breadcrumb Home La rhinite allergique (RA) est la maladie immunologique la plus fr\u00e9quente, touchant quelque 400 millions de personnes dans le monde. Elle varie d\u2019une g\u00eane mineure \u00e0 une RA s\u00e9v\u00e8re : une maladie d\u00e9bilitante ayant un impact significatif sur la qualit\u00e9 de vie (QdV). De plus, la RA est susceptible d\u2019entra\u00eener plusieurs comorbidit\u00e9s, dont l\u2019asthme allergique. Avec les nouvelles connaissances et options de traitement disponibles, il est de plus en plus n\u00e9cessaire de (re)d\u00e9finir les d\u00e9finitions cl\u00e9s afin de permettre la communication entre les diff\u00e9rentes sp\u00e9cialit\u00e9s traitant la RA. Le Forum europ\u00e9en pour la recherche et l\u2019\u00e9ducation sur l\u2019allergie et les maladies des voies respiratoires (EUFOREA) organisera une r\u00e9union d\u2019experts de diff\u00e9rentes sp\u00e9cialit\u00e9s traitant la RA afin de trouver un consensus sur plusieurs d\u00e9finitions et stades de la maladie. S\u2019appuyant sur les r\u00e9unions de consensus sur l\u2019asthme (Londres, avril 2023) et la RSC (Bruxelles, juin 2023), l\u2019EUFOREA se concentrera d\u00e9sormais sur la RA en tant que maladie afin de trouver un consensus sur les nouveaux stades de la maladie et les cibles th\u00e9rapeutiques. Cet \u00e9v\u00e9nement se tient sur invitation ! D\u00e9finir les points suivants : Le contr\u00f4le de la RA La r\u00e9mission et la gu\u00e9rison de la RA La r\u00e9currence\/exacerbation de la RA La modification de la maladie dans la RA Conseiller sur la pr\u00e9vention de la RA Les lacunes dans la prise en charge de la RA Suggestions pour am\u00e9liorer la prise en charge de la RA Ambitions futures pour la prise en charge de la RA Membres du corps professoral Prof. Glenis Scadding Copr\u00e9sidente de l\u2019\u00e9v\u00e9nement Pr Philippe Gevaert Copr\u00e9sidente de l\u2019\u00e9v\u00e9nement Dr Sophie Scheire Prof. Joaquim Mullol<\/p>\n","protected":false},"author":2,"featured_media":38091,"comment_status":"open","ping_status":"closed","template":"elementor_theme","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-38090","events","type-events","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.7 (Yoast SEO v28.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024 - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024\" \/>\n<meta property=\"og:description\" content=\"Breadcrumb Home La rhinite allergique (RA) est la maladie immunologique la plus fr\u00e9quente, touchant quelque 400 millions de personnes dans le monde. Elle varie d\u2019une g\u00eane mineure \u00e0 une RA s\u00e9v\u00e8re : une maladie d\u00e9bilitante ayant un impact significatif sur la qualit\u00e9 de vie (QdV). De plus, la RA est susceptible d\u2019entra\u00eener plusieurs comorbidit\u00e9s, dont l\u2019asthme allergique. Avec les nouvelles connaissances et options de traitement disponibles, il est de plus en plus n\u00e9cessaire de (re)d\u00e9finir les d\u00e9finitions cl\u00e9s afin de permettre la communication entre les diff\u00e9rentes sp\u00e9cialit\u00e9s traitant la RA. Le Forum europ\u00e9en pour la recherche et l\u2019\u00e9ducation sur l\u2019allergie et les maladies des voies respiratoires (EUFOREA) organisera une r\u00e9union d\u2019experts de diff\u00e9rentes sp\u00e9cialit\u00e9s traitant la RA afin de trouver un consensus sur plusieurs d\u00e9finitions et stades de la maladie. S\u2019appuyant sur les r\u00e9unions de consensus sur l\u2019asthme (Londres, avril 2023) et la RSC (Bruxelles, juin 2023), l\u2019EUFOREA se concentrera d\u00e9sormais sur la RA en tant que maladie afin de trouver un consensus sur les nouveaux stades de la maladie et les cibles th\u00e9rapeutiques. Cet \u00e9v\u00e9nement se tient sur invitation ! D\u00e9finir les points suivants : Le contr\u00f4le de la RA La r\u00e9mission et la gu\u00e9rison de la RA La r\u00e9currence\/exacerbation de la RA La modification de la maladie dans la RA Conseiller sur la pr\u00e9vention de la RA Les lacunes dans la prise en charge de la RA Suggestions pour am\u00e9liorer la prise en charge de la RA Ambitions futures pour la prise en charge de la RA Membres du corps professoral Prof. Glenis Scadding Copr\u00e9sidente de l\u2019\u00e9v\u00e9nement Pr Philippe Gevaert Copr\u00e9sidente de l\u2019\u00e9v\u00e9nement Dr Sophie Scheire Prof. Joaquim Mullol\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-27T07:35:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/AR-Consensus-Meeting-Teaser-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1748\" \/>\n\t<meta property=\"og:image:height\" content=\"1015\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/events\\\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/events\\\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\\\/\",\"name\":\"R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024 - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/events\\\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/events\\\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/AR-Consensus-Meeting-Teaser-.png\",\"datePublished\":\"2024-12-03T05:56:18+00:00\",\"dateModified\":\"2026-08-27T07:35:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/events\\\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/fr\\\/events\\\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/events\\\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/AR-Consensus-Meeting-Teaser-.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/AR-Consensus-Meeting-Teaser-.png\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/events\\\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/events\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024 - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024","og_description":"Breadcrumb Home La rhinite allergique (RA) est la maladie immunologique la plus fr\u00e9quente, touchant quelque 400 millions de personnes dans le monde. Elle varie d\u2019une g\u00eane mineure \u00e0 une RA s\u00e9v\u00e8re : une maladie d\u00e9bilitante ayant un impact significatif sur la qualit\u00e9 de vie (QdV). De plus, la RA est susceptible d\u2019entra\u00eener plusieurs comorbidit\u00e9s, dont l\u2019asthme allergique. Avec les nouvelles connaissances et options de traitement disponibles, il est de plus en plus n\u00e9cessaire de (re)d\u00e9finir les d\u00e9finitions cl\u00e9s afin de permettre la communication entre les diff\u00e9rentes sp\u00e9cialit\u00e9s traitant la RA. Le Forum europ\u00e9en pour la recherche et l\u2019\u00e9ducation sur l\u2019allergie et les maladies des voies respiratoires (EUFOREA) organisera une r\u00e9union d\u2019experts de diff\u00e9rentes sp\u00e9cialit\u00e9s traitant la RA afin de trouver un consensus sur plusieurs d\u00e9finitions et stades de la maladie. S\u2019appuyant sur les r\u00e9unions de consensus sur l\u2019asthme (Londres, avril 2023) et la RSC (Bruxelles, juin 2023), l\u2019EUFOREA se concentrera d\u00e9sormais sur la RA en tant que maladie afin de trouver un consensus sur les nouveaux stades de la maladie et les cibles th\u00e9rapeutiques. Cet \u00e9v\u00e9nement se tient sur invitation ! D\u00e9finir les points suivants : Le contr\u00f4le de la RA La r\u00e9mission et la gu\u00e9rison de la RA La r\u00e9currence\/exacerbation de la RA La modification de la maladie dans la RA Conseiller sur la pr\u00e9vention de la RA Les lacunes dans la prise en charge de la RA Suggestions pour am\u00e9liorer la prise en charge de la RA Ambitions futures pour la prise en charge de la RA Membres du corps professoral Prof. Glenis Scadding Copr\u00e9sidente de l\u2019\u00e9v\u00e9nement Pr Philippe Gevaert Copr\u00e9sidente de l\u2019\u00e9v\u00e9nement Dr Sophie Scheire Prof. Joaquim Mullol","og_url":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","article_modified_time":"2026-08-27T07:35:40+00:00","og_image":[{"width":1748,"height":1015,"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/AR-Consensus-Meeting-Teaser-.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/","url":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/","name":"R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024 - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/AR-Consensus-Meeting-Teaser-.png","datePublished":"2024-12-03T05:56:18+00:00","dateModified":"2026-08-27T07:35:40+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/AR-Consensus-Meeting-Teaser-.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/AR-Consensus-Meeting-Teaser-.png","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/fr\/events\/reunion-de-consensus-de-leuforea-sur-la-rhinite-severe-non-controlee-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/www.euforea.org\/fr\/events\/"},{"@type":"ListItem","position":3,"name":"R\u00e9union de consensus de l\u2019EUFOREA sur la rhinite s\u00e9v\u00e8re non contr\u00f4l\u00e9e 2024"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/fr\/#website","url":"https:\/\/www.euforea.org\/fr\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/fr\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/events\/38090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/events"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/events"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=38090"}],"version-history":[{"count":2,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/events\/38090\/revisions"}],"predecessor-version":[{"id":42323,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/events\/38090\/revisions\/42323"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/38091"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=38090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=38090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=38090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}